ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 129 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,035,895 | -56.1% | 3,097,852 | -37.7% | 0.01% | -57.1% |
| Q2 2023 | $6,915,250 | +20.8% | 4,975,000 | +38.2% | 0.02% | +16.7% |
| Q1 2023 | $5,724,000 | -62.1% | 3,600,000 | +48.3% | 0.02% | -64.7% |
| Q4 2022 | $15,120,210 | -20.5% | 2,427,000 | -14.5% | 0.05% | -32.9% |
| Q3 2022 | $19,017,000 | +181.3% | 2,838,300 | +167.0% | 0.08% | +162.1% |
| Q2 2022 | $6,761,000 | -62.8% | 1,063,096 | +64.0% | 0.03% | -65.9% |
| Q1 2021 | $18,182,000 | +6257.3% | 648,200 | +13404.2% | 0.08% | +4150.0% |
| Q4 2019 | $286,000 | -98.1% | 4,800 | -98.9% | 0.00% | -97.9% |
| Q3 2019 | $15,375,000 | +395.0% | 419,390 | +528.1% | 0.09% | +487.5% |
| Q2 2019 | $3,106,000 | -64.4% | 66,773 | -69.2% | 0.02% | -60.0% |
| Q1 2019 | $8,717,000 | -61.3% | 217,100 | -57.2% | 0.04% | -57.0% |
| Q3 2018 | $22,509,000 | +57.7% | 507,300 | +39.3% | 0.09% | +63.2% |
| Q2 2018 | $14,269,000 | +685.7% | 364,100 | +372.9% | 0.06% | +307.1% |
| Q3 2015 | $1,816,000 | -42.7% | 77,000 | +98.5% | 0.01% | -36.4% |
| Q2 2015 | $3,172,000 | +632.6% | 38,800 | +262.6% | 0.02% | +633.3% |
| Q4 2014 | $433,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |